A Phase 1 Study of ATV-1601 in Patients With Advanced Cancer That Have AKT1 E17K Mutations
Atavistik Bio, Inc
Atavistik Bio, Inc
Pfizer
AstraZeneca
AstraZeneca
Genmab
DL Analytics
PinkDx, Inc.
Leap Therapeutics, Inc.
Incyte Corporation
Leap Therapeutics, Inc.
Gradalis, Inc.
Aesculap AG
Precision Biologics, Inc
Revolution Medicines, Inc.
Elevation Oncology